FDG PET in solitary metastastic/secondary tumor of the kidney: A report of three cases and a review of the relevant literature-Reference-Cited by-同舟云学术

FDG PET in solitary metastastic/secondary tumor of the kidney: A report of three cases and a review of the relevant literature

Published:2006-01 Issue:1 Volume:20 Page:79-82
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Kaneta Tomohiro,Hakamatsuka Takashi,Yamada Takayuki,Takase Kei,Sato Akihiro,Higano Shuichi,Kinomura Shigeo,Fukuda Hiroshi,Takahashi Shoki,Yamada Shogo

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02985596.pdf

Reference24 articles.

1. Hofer C, Kubler H, Hartung R, Breul J, Avril N. Diagnosis and monitoring of urological tumors using positron emission tomography.Eur Urol 2001; 40: 481–487.

2. Bracken RB, Chica G, Johnson DE, Luna M. Secondary renal neoplasms: an autopsy study.South Med J 1979; 72: 806–807.

3. Pollack HM, Banner MP, Amendola MA. Other malignant neoplasms of the renal parenchyma.Semin Roentgenol 1987; 22: 260–274.

4. Klinger M. Secondary tumors of the genitourinary tract.J Urol 1951; 65: 144–153.

5. Abrams H, Spira R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases.Cancer 1950; 3: 74–85.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG PET/CT in Solitary Isolated Renal Metastasis From Squamous Cell Lung Cancer;Clinical Nuclear Medicine;2023-11-29

2. Diagnostic value of 18F-FDG PET/CT in primary and metastatic renal tumors: a pilot study;Clinical and Translational Imaging;2023-09-14

3. FDG PET/CT in Unilateral Renal Metastasis From Colon Cancer;Clinical Nuclear Medicine;2022-07-26

4. Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy;Clinical Nuclear Medicine;2019-01-30

5. FDG PET/CT in 2 Cases of Renal Metastasis From Esophageal Squamous Cell Carcinoma;Clinical Nuclear Medicine;2017-11